PhRMA Chief: Time To Play Offense On Price Debate
This article was originally published in Scrip
Executive Summary
Drug makers have played defense long enough in the debate over skyrocketing prices of medicines and it's time to go on the offense and drive the discussion, declared the new president and CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA).